IDEAYA Biosciences, Inc. Common Stock

Go to IDEAYA Biosciences, Inc. Common Stock Website

$24.12

-0.88 (-3.52%)
Live
Previous Close

$25

Day Range

$23.395 - $25.8199

Previous Day Range

$23.76 - $25.08

Market Cap

$2.1 billion USD

Day Vol.

1.6 million

Previous Day Vol.

1.3 million

Currency

USD

Primary Exchange

Nasdaq

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug dis...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

IDEAYA Biosciences reported a Q2 2025 net loss of $0.88 per share with no revenue, but maintained strong cash reserves of $991.9 million. The company continues advancing its cancer therapy pipeline, with key clinical trials progressing in darovasertib and other oncology programs.

Related tickers: IDYA, GILD, GSK, PFE.

Read Full Article

The melanoma market is expected to surge between 2025-2034 due to increasing incidence, emerging therapies, heightened UV exposure, and diagnostic advancements. Several new therapies are in development, with potential to transform treatment options for melanoma patients.

Related tickers: REPL, IDYA, BMY, CELGr.

Read Full Article
Trending Tickers

Please sign in to view